Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Budgeting is crucial for effective financial planning. Discover the ways it can help you achieve your financial goals more efficiently.
22,426 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A federal judge blocked DOJ subpoenas aimed at Fed Chair Powell over a congressional hearing on the central bank’s HQ...
Two pharma giants, two very different growth stories. This guide breaks down why Eli Lilly might be the best growth s...
Apple abandons the stalemate of building bigger AI models. In a bold pivot, the company opens iOS 27 to rival assista...
A big fund move can shift sentiment and pricing. This article breaks down the implications of baillie gifford dumps 2...
The social security cola forecast for 2027 climbs to 3.9%, driven by persistent inflation in housing and energy. Reti...
Three dividend-focused ETFs—VYM, SCHD and SPHD—could deliver roughly $7,300 per year from about 690 underlying stocks...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
Tired of trying to time the market? This guide shows a simple, proven path: buy solid dividend stocks and hold them f...
Investing when the market hits new highs creates anxiety for many. This article dives into whether it's truly safe to...
Rent is due on the first, but most workers are paid on varied schedules. A growing body of data points to a hidden co...
A new line of thinking from Google DeepMind suggests AI consciousness debates may spill into policy and crypto govern...